Home

Linda Bain

CIK 1578407 · Chief Financial Officer · last filed 2026-07-01

Linda Bain is a Chief Financial Officer who has filed 30 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing, for AUTL, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$643.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $335.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$335.1K

Companies

6

Total Filings

30

Lifetime Open-Market Net

-$643.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AUTL Director — $1.82 — $0 1 2026-07-01
ARVN Director 41,572 $8.06 $335.1K $0 7 2026-06-26
Codiak BioSciences, Inc. (CDAK) Delisted Chief Financial Officer 0 $0.06 $0 -$10.1K 8 2023-03-30
VBI Vaccines Inc/BC (VBIV) Delisted Director — $0.07 — $0 2 2022-01-31
Adverum Biotechnologies, Inc. (AAVL) Delisted Chief Financial Officer 41,930 — — -$253.7K 6 2015-08-25
bluebird bio, Inc. (BLUE) Delisted VP, Fin. & Business Operations 0 $4.97 $0 -$380.1K 6 2014-03-05

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 AUTL Grant (A) — $0 EDGAR
2026-06-26 ARVN Grant (A) +15,527 $0 EDGAR
2025-06-27 ARVN Grant (A) +16,025 $0 EDGAR
2024-05-31 ARVN Grant (A) +5,899 $0 EDGAR
2023-06-20 ARVN Grant (A) +4,121 $0 EDGAR
2023-03-30 Codiak BioSciences, Inc. (CDAK) Delisted Sell (S) −13,412 -$2.3K EDGAR
2023-02-21 Codiak BioSciences, Inc. (CDAK) Delisted Mixed +10,292 -$6.8K EDGAR
2023-01-26 Codiak BioSciences, Inc. (CDAK) Delisted Grant (A) — $0 EDGAR
2023-01-23 Codiak BioSciences, Inc. (CDAK) Delisted Mixed +3,120 -$1.1K EDGAR
2022-09-20 Codiak BioSciences, Inc. (CDAK) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.